Up to now, LINC00511 has been showed to be overexpressed in many kinds of tumor tissues, and exert oncogenic effects on lung cancer [14,15], breast cancer [16–21], pancreatic cancer [22], bladder cancer [23], osteosarcoma [24], and tongue squamous cell carcinoma [25]. Here, LINC00511 is linked to urinary bladder cancer.